[1]王勇,唐川,兰曦,等.沉默CD133基因对CD133+肝癌干细胞放射敏感性的影响[J].第三军医大学学报,2012,34(23):2373-2377.
 Wang Yong,Tang Chuan,Lan Xi,et al.RNAi targeting CD133 enhances radiosensitivity in CD133 positive liver cancer stem cells[J].J Third Mil Med Univ,2012,34(23):2373-2377.
点击复制

沉默CD133基因对CD133+肝癌干细胞放射敏感性的影响(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
34卷
期数:
2012年第23期
页码:
2373-2377
栏目:
论著
出版日期:
2012-12-15

文章信息/Info

Title:
RNAi targeting CD133 enhances radiosensitivity in CD133 positive liver cancer stem cells
作者:
王勇唐川兰曦冉雪琪邹冬玲曹姝李芳李少林
重庆医科大学基础医学院放射医学教研室;重庆医科大学附属永川医院神经内科;重庆市肿瘤研究所:放疗科,妇瘤科
Author(s):
Wang Yong Tang Chuan Lan Xi Ran Xueqi Zou Donglin Cao Shu Li Fang Li Shaolin
Department of Radiation Medicine, College of Basic Medical Sciences, Chongqing Medical University, Chongqing, 400016; Department of Neurology, Yongchuan Affiliated Hospital of Chongqing Medical University, Chongqing, 402160; Department of Radiation Oncology, Department of Gynecological Oncology, Chongqing Tumor Institute, Chongqing, 400030, China
关键词:
CD133肝癌干细胞RNA干扰放射敏感性
Keywords:
CD133liver CSCsRNA interferenceradiosensitivity
分类号:
R73-362; R730.55; R735.7
文献标志码:
A
摘要:
目的      研究沉默CD133基因对人肝癌CD133+-HepG2干细胞放射敏感性的影响。      方法       免疫磁珠分选HepG2细胞;流式细胞术检测分选前后CD133表达率;NOD/SCID小鼠成瘤实验验证其干性;靶向沉默CD133基因并分组(空白组、阴性感染组、阳性感染组);RT-PCR和Western blot检测各组CD133基因mRNA和蛋白表达;克隆形成实验检测各组细胞经不同剂量照射后的克隆形成率及存活率,绘制存活曲线并计算各组细胞放射生物学参数D0、Dq、N及放射增敏比(SER);流式细胞术检测各组细胞周期及凋亡情况。      结果       流式细胞术检测结果显示,分选前后CD133表达率分别为(1.36±0.20)%和(87.62±1.92)%。CD133+细胞在细胞数为1×103/ml时即可形成皮下移植瘤。RT-PCR和Western blot检测结果显示,阳性感染组CD133 mRNA和蛋白表达均受到明显抑制。流式细胞术检测结果显示:阳性感染组G1、S期减少G2期增加,细胞凋亡率明显增加。克隆形成实验显示阳性感染组D1、Dq、N值与SF1均减小,放射敏感性明显增强,其SER为(1.37±0.02),差异均具有统计学意义(P<0.05)。      结论       CD133作为肝癌干细胞的表面标志物之一,可能成为肝癌干细胞放射治疗增敏的靶点。
Abstract:
Objective       To determine the effects of CD133-downregulation on the radiosensitivity of CD133+HepG2 cancer stem cells (CSCs) in hepatocellular carcinoma.       Methods       Magnetic-activated cell sorting (MACS) was used to isolate CD133+ and CD133-cells from HepG2 cells. Flow cytometry was used to detect the expression of CD133 before and after cells isolation. The NOD/SCID mice transplantation tumor experiments were performed to validate the cancer stem-like properties of sorted CD133+ cells. Targeted silencing towards CD133 gene was performed, and the cells were divided into blank control group, negative-transfection group and positive-transfection group. RT-PCR and Western blotting were used to detect the mRNA and protein expression of CD133. Colony formation assay was applied to detect colony formation efficiency and survival rate after irradiation at different doses. Survival curve was drawn and radiobiology parameters D0, Dq, N and SER (sensitive enhancement ratio) were counted. Flow cytometry was used to test cell cycle and apoptosis.       Results       Flow cytometry indicated that the expression rate of CD133 was (1.36±0.20)% and (87.62±1.92)% respectively before and after MACS isolation. When the obtained CD133+ cells at a dose of 1×103/ml, subcutaneous tumor was found in the NOD/SCID mice after implantation. The expression levels of CD133 at mRNA and protein level were significantly decreased in positive-transfection group. After CD133-downregulation, the cells at G1 and S phase were decreased whereas those at G2 phase and apoptotic rate were increased significantly. Colony formation results showed that D0, Dq, N and SF2were decreased while and SER was increased significantly in positive-transfection group (P<0.05).       Conclusion       CD133, as a marker of CSCs in liver cancer, could be a target for radiosensitization in liver CSCs treatment.

参考文献/References:

王勇, 唐川, 兰曦, 等. 沉默CD133基因对CD133+肝癌干细胞放射敏感性的影响[J]. 第三军医大学学报,2012,34(23):2373-2377.

相似文献/References:

[1]陈克力,梁后杰,江恒,等.人HCT116结肠癌细胞系中CD133+结肠癌干细胞分离及鉴定[J].第三军医大学学报,2009,31(04):330.
 CHEN Ke-li,LIANG Hou-jie,JIANG Heng,et al.Isolation and identification of CD133+ colon cancer stem cells from colon cancer cell line HCT116[J].J Third Mil Med Univ,2009,31(23):330.
[2]蒋娟,易亭伍,张瑜,等.非小细胞肺癌的肿瘤干细胞与非肿瘤干细胞中表皮生长因子受体基因异质性的研究[J].第三军医大学学报,2012,34(20):2039.
 Jiang Juan,Yi Tingwu,Zhang Yu,et al.Genetic heterogeneity of EGFR in cancer and non-cancer stem cells from non-small cell lung cancer[J].J Third Mil Med Univ,2012,34(23):2039.
[3]尚立娜,杨爱军,王晨昱,等.内皮细胞对结肠癌细胞系SW480中CD133+细胞表达VEGF的影响[J].第三军医大学学报,2010,32(16):1740.
 Shang Lina,Yang Aijun,Wang Chenyu,et al.Effect of endothelial cells on VEGF expression in CD133+ cells from SW480 cells[J].J Third Mil Med Univ,2010,32(23):1740.
[4]张军荣,穆继英,杨爱军,等.5-氟尿嘧啶筛选残存结肠癌细胞的生物学特点及其与CD133表达的关系[J].第三军医大学学报,2011,33(01):18.
 Zhang Junrong,Mu Jiying,Yang Aijun,et al.Biological characteristics of colon carcinoma cells surviving 5-fluorouracil treatment and their relationship with CD133 expression[J].J Third Mil Med Univ,2011,33(23):18.
[5]赵文思,罗弋,黎博一,等.人肺癌H1299肿瘤干细胞样细胞的分离培养及鉴定[J].第三军医大学学报,2016,38(07):708.
 Zhao Wensi,Luo Yi,Li Boyi,et al.Isolation and identification of cancer stem-like cells from lung cancer H1299 cells[J].J Third Mil Med Univ,2016,38(23):708.
[6]胡欣春,魏益平,彭金华,等.miR-4686对A549细胞球增殖的调控作用及其机制研究[J].第三军医大学学报,2014,36(04):340.
 Hu Xinchun,Wei Yiping,Peng Jinhua,et al.Regulation of miR-4686 on proliferation in A549 spheres[J].J Third Mil Med Univ,2014,36(23):340.
[7]陈凯,李中虎,江鹏,等.CD44、CD133和TF与肝癌中门静脉癌栓形成及恶性预后相关[J].第三军医大学学报,2014,36(10):1068.
 Chen Kai,Li Zhonghu,Jiang Peng,et al.CD44, CD133 and TF correlate with formation of portal vein tumor thrombus and poor prognosis in patients with hepatocellular carcinoma[J].J Third Mil Med Univ,2014,36(23):1068.
[8]金世龙,张鹏,匡远黎,等.低浓度亚砷酸钠抑制Oct4、Sox2基因表达诱导肝癌干细胞分化[J].第三军医大学学报,2015,37(02):116.
 Jin Shilong,Zhang Peng,Kuang Yuanli,et al.Low concentration of sodium arsenite induces differentiation of liver cancer stem cells through inhibiting Oct4 and Sox2 expression in hepatocellular carcinoma cells[J].J Third Mil Med Univ,2015,37(23):116.
[9]彭维,赵湘湘,苏立,等.miR-125b对肝癌干细胞自我更新能力的调控作用[J].第三军医大学学报,2015,37(11):1070.
 Peng Wei,Zhao Xiangxiang,Su Li,et al.miR-125b regulates self-renewal in liver cancer stem cells[J].J Third Mil Med Univ,2015,37(23):1070.
[10]谭烨,尤楠,郑璐,等.COMMD7调控肝癌干细胞间充质-上皮转化过程抑制其侵袭转移能力[J].第三军医大学学报,2017,39(17):1691.
 TAN Ye,YOU Nan,ZHENG Lu,et al.COMMD7 inhibits migration and invasion in liver cancer stem cells via regulating mesenchymalepithelial transition[J].J Third Mil Med Univ,2017,39(23):1691.
[11]贾茜,高建,张小丽,等.HepG2、Hep3B细胞中肿瘤干细胞相关标志分子的表达[J].第三军医大学学报,2012,34(09):852.
 Jia Qian,Gao Jian,Zhang Xiaoli,et al.Expression of cancer stem cell-associated markers in liver cancer cell lines HepG2 and Hep3B[J].J Third Mil Med Univ,2012,34(23):852.
[12]侯妍利,唐敏,陈兴月,等.分离、鉴定CD133+人肝癌干细胞以及131I-CD133mAb对其生物学效应的影响[J].第三军医大学学报,2014,36(03):222.
 Hou Yanli,Tang Min,Chen Xingyue,et al.Isolation and identification of CD133-positive liver cancer stem cells and 131I-CD133mAb biological effects on the cells[J].J Third Mil Med Univ,2014,36(23):222.

更新日期/Last Update: 2012-12-04